MabCure, Inc.
MBCI · OTC
12/31/2011 | 9/30/2011 | 6/30/2011 | 3/31/2011 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 45.3% | – | – | – |
| Other Income/Exp. Net | -$11 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$11 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$0 | -$1 | -$0 |
| % Margin | -2,239% | – | – | – |
| EPS | -0.18 | -0.005 | -0.008 | -0.007 |
| % Growth | -3,900% | 44.4% | -11% | – |
| EPS Diluted | -0.18 | -0.005 | -0.008 | -0.007 |
| Weighted Avg Shares Out | 64 | 63 | 63 | 63 |
| Weighted Avg Shares Out Dil | 64 | 63 | 63 | 63 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$11 | -$0 | -$0 | -$0 |
| % Margin | -2,233.1% | – | – | – |